Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Bio Products Laboratory Ltd.
Description16% IgG product made from human plasma
Molecular Target
Mechanism of ActionImmune modulation; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase III
Standard IndicationPrimary immunodeficiency disease (PIDD)
Indication DetailsTreat primary immunodeficiency disease (PIDD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today